A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.
Saved in:
| Title: | A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma. |
|---|---|
| Authors: | Dasyam N; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Sharples KJ; Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Barrow C; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Huang Y; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Bauer E; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Mester B; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Wood CE; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Authier-Hall A; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Dzhelali M; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Ostapowicz T; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Kumar R; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Lowe J; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Maxwell A; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Burn OK; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Williams GM; School of Chemical Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Carley SE; School of Chemical Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Caygill G; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand., Jones J; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand., Chan STS; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand., Hinder VA; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Macapagal J; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., McCusker M; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Weinkove R; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Brimble MA; School of Chemical Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Painter GF; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand., Findlay MP; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Dunbar PR; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand.; School of Biological Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand., Gasser O; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand. ogasser@malaghan.org.nz., Hermans IF; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand. ihermans@malaghan.org.nz.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand. ihermans@malaghan.org.nz. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Jul; Vol. 72 (7), pp. 2267-2282. Date of Electronic Publication: 2023 Mar 07. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-023-03400-y |
